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The unique properties of silk fibroin were combined with keratin to develop new wound-dressing materials. Silk
fibroin/keratin (SF/K) films were prepared to reduce high levels of elastase found on chronic wounds. This improved
biological function was achieved by the incorporation of a small peptide synthesized based on the reactive-site
loop of the Bowman-Birk Inhibitor (BBI) protein. In vitro degradation and release were evaluated using porcine
pancreatic elastase (PPE) solution as a model of wound exudate. It was found that biological degradation and
release rate are highly dependent on film composition. Furthermore, the level of PPE activity can be tuned by
changing the film composition, thus showing an innovative way of controlling the elastase-antielastase imbalance
found on chronic wounds.
1. Introduction
Wound healing is a specific biological process related to the
general phenomenon of growth and tissue regeneration. Wound
healing progresses through a series of interdependent and
overlapping stages in which a variety of cellular and matrix
components act together to reestablish the integrity of damaged
tissue and the replacement of lost tissue.1-3 The interruption
of the orderly sequence of events during the healing process
results in chronic wounds.4,5
Skin ulcers are the most common types of chronic wounds
and are the focus of this study. These wounds can be created
by many factors including vascular insufficiency, prolonged
inflammation, pressure necrosis, physical agents, infection, and
cancer.6 Chronic wounds stop the healing process in the
inflammatory phase, remaining nonhealed for several months
or even years.
Excessive amounts of exudates are present in these types of
wounds. Although wound exudate is a key component in all
stages of the wound healing, irrigating the wound continuously
and keeping it moist,1,7 the excessive production of exudates
can cause maceration of healthy skin tissue around the wound,
inhibiting the healing. In addition, exudate from chronic wounds
differs from acute wounds fluid, containing higher levels of
tissue destructive protease enzymes, namely, matrix metallo-
proteinases (MMPs) and polymorphonuclear (PMN) elastase.8-12
The excessive action of elastase leads to reduce amounts of
growth factors13 and endogenous proteinase inhibitors, causing
the cleavage of collagen, elastin, and fibronectin and conse-
quently the destruction of extracellular matrix.10 As a result,
there has been considerable interest in the design of inhibitors
that restore the elastase-antielastase imbalance.
Bowman-Birk inhibitors (BBIs) are small plant proteins of
typically 60 to 90 residues stabilized by seven disulfide bridges.
They have a symmetrical structure of two tricyclic domains,
each containing an independent binding loop.14-17 The inhibi-
tion of serine proteinases is often mediated by these binding
regions. The reactive site loop is fixed in a “canonical”
conformation that is complementary to the proteinase active
site.18,19 Small peptides mimicking the reactive-site loop of BBI
protein have shown to retain much of the inhibitory activity of
the complete protein.20
This study focus on the development of wound dressings with
the ability to control elastase activity. Silk fibroin and keratin
blends were used to incorporate a synthetic BBI peptide. The
peptide sequence was removed from a combinatorial library of
synthetic BBI-based peptides.21 The excellent properties of silk
fibroin such as high mechanical strength, low degradability, and
biocompatibility were combined with keratin protein to modulate
the physical and bifunctional properties of the final material to
fulfill the wound healing needs.
2. Materials and Methods
2.1. Materials. The porcine pancreatic elastase (PPE) was
purchase from Sigma, Spain. The peptide 5(6)-carboxyfluorescein-
YCQPPWSATCF-OH was synthesized by JPT Peptide Technologies
GmbH (Germany). The NIH 3T3 cell line (mouse embryonic
fibroblasts) was purchased from the European Collection of Cell
Cultures (ECACC). All other reagents were analytical grade and
purchased from Sigma, Spain.
2.2. Preparation of Aqueous Silk Fibroin and Keratin Solu-
tions. Silk cocoons from B. mori were donated from “Sezione
Specializzata per la Bachicoltura” (Padova). Silk fibroin (SF) was
purified from its sericin content, as previously described.22 The cocoons
were cut, cleaned from debris and larvae, and autoclaved for 30 min at
120 °C. SF was then thoroughly washed with distilled water and dried
overnight at room temperature.
We prepared SF solution 1% (w/v) by dissolving 1 g of degummed
silk fibers into 10 mL of saturated aqueous LiBr at 60 °C for 3 h. The
solution was then diluted by the addition of 90 mL of deionized water.
We prepared keratin (K) solution 1% (w/v) by immersing 1 g of
delipided wool fabric, provided by Albano Antunes Morgado Lda
(Portugal), in 10 mL of a solution containing 8 M urea, 0.2 M SDS,
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and 0.5 M Na2S2O5. The mixture was heated to 60 °C for 12 h. Both
solutions were filtered and dialyzed against distilled water using
cellulose tubing (molecular-weight cutoff of 12 00-14 000 Da) until
complete removal of salts was achieved.
2.3. Preparation of Blended Silk Fibroin/Keratin Films. Keratin
(K) and SF solutions (10 mL of final volume) were blended in the
ratios of 80/20, 60/40, and 40/60 of SF/K. The blends were cast in
plastic Petri dishes with a circular area of 40 cm2 and dried at room
temperature. The controls are 100% SF and 100% K. The resulting
films were 0.03 mm in average thickness.
To induce the transition of SF from random coil to -sheet structure
and consequently insolubility, all films were immersed in 90% (v/v)
methanol solution for 30 min and then washed in distilled water and
air-dried. All films used were submitted to this treatment.
2.4. In Vitro Degradation. SF/K films were incubated, for 14 days,
at 37 °C in a solution containing 0.1 U/mL of PPE in 100 mM Tris-
HCl buffer, pH 8.0. The control samples were incubated in the same
buffer without PPE and submitted to the same conditions.
Solutions were changed every 12 h. At designated time points,
samples were washed thoroughly with distilled water, dried in a
desiccator, and weighed to estimate the extent of degradation by the
following equation
where m0 is the initial dry mass of the sample and mf is the final dry
mass.
2.5. Swelling Ratio of SF/K Films. Dry SF/K films (60 °C for 24 h)
were immersed in 100 mM Tris-HCl buffer, pH 8.0 at 37 °C for 24 h.
The excess of buffer was removed, and the wet weight of the film was
determined. The swelling ratio of the film was calculated as follows
where WS is the mass of the swollen material and Wd is the initial dry
mass.
2.6. Protein Adsorption to SF/K Films. SF/K films were incubated
with 0.1 U/mL of PPE solution at 37 °C for 24 h. We determined
adsorption of the proteins to the SF/K films by measuring the reduction
of elastase activity in the supernatant.
2.7. Atomic Force Microscopy (AFM). Surface analysis of the
films was performed in tapping mode using a Nanoscope III scanning
probe microscope controller (Multimode Digital Instruments) with a
silicon probe (RTESP14, Veeco). Root mean square (rms) roughness
data were collected from each sample according to manufacture
instructions. Two scans of 10 µm × 10 µm edge regions were taken
for each dry sample.
2.8. Cytotoxicity Evaluation. SF/K films were tested for cytotox-
icity according to the ISO standards (10993-5, 2009). Both, tests by
direct contact and tests on extract were performed to analyze the
cytotoxicity of the developed materials.
Cell Culture. The NIH 3T3 cell line (mouse embryonic fibroblasts)
was maintained in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% (v/v) of fetal bovine serum (FBS) inactivated
(20 min at 56 °C) and 1% (v/v) of penicillin/streptomycin (PS; 10 000
units/mL penicillin and 10 000 µg/mL streptomycin) all supplied by
Gibco. The cells were maintained at 37 °C in a humidified atmosphere
of 5% CO2. The medium was refreshed every 2 to 3 days. At
preconfluence, cells were harvested using trypsin (0.25% (w/v) trypsin,
0.1% (w/v) glucose, and 0.05% (w/v) ethylenediaminetetraacetic acid
(EDTA) in phosphate-buffered saline solution (PBS)) and further used
as described in the following paragraphs.
Test on Extracts. Discs (φ ) 8 mm) were punched out of the
films with skin biopsy punches (Acu-Punch) and sterilized by immersion
in serial dilutions of ethanol (90, 70, and 50% v/v) for 15 min, then
hydrated and rinsed with PBS. The extracts were obtained by the
incubation of the membranes in 2 mL of DMEM supplemented with
1% (v/v) PS in an orbital incubator at 37 °C for either 24 and 72 h at
180 rpm. At the end of these time points, the membranes were removed,
and the extracts were obtained. Before use, the extracts were supple-
mented with 10% (v/v) FBS and subsequently serially diluted (100,
50, 25, and 10% (v/v)) in complete culture medium. A sample of the
extract vehicle subjected to the same extraction conditions was used
as a negative control, whereas a 1% (v/v) solution of Triton X-100
(Sigma) prepared in fresh culture medium was used as a positive control.
Cells seeded at a density of 5 × 103 cells/200 µL/well on 96-well tissue
culture polystyrene (TCPS) plates (Greiner Bio-one) were exposed to
the serial dilutions of the extracts and incubated at 37 °C under a
humidified atmosphere of 5% CO2. At the end of each culture period
(24 and 72 h), the cell viability was assessed using a resazurin based
assay. Medium containing extract was refreshed ever 24 h of contact
with the cells.
Test by Direct Contact. This test was performed to monitor the effect
of the materials on fibroblast proliferation upon direct contact. Discs,
prepared and sterilized as previously described (φ ) 14 mm), were
gently place in 24-well TCPS plates (Greiner Bio-one) and fixed with
sterilized silicone rings with a 12 mm internal diameter (Epidor, Spain).
The discs were let to dry overnight in a laminar flow hood. Prior to
cell seeding, discs were equilibrated in PBS and subsequently in DMEM
with 1% v/v PS (37 °C for 1 h). We seeded and cultured 2 × 104
cells/mL/well for 24, 48, and 72 h. TCPS in the presence of the o-rings
was used as control. Medium was refreshed daily. After each incubation
periods, cell proliferation was determined quantitatively using the
resazurin based assay, and cell morphology was assessed using F-actin
fluorescent labeling.
Resazurin Assay. Resazurin is a blue, nonfluorescent molecule that
is reduced by several mitochondrial and cytoplasmic enzymes to a pink
fluorescent product, called resofurin. 10% (v/v) of resazurin solution
(0.1 mg/mL, in PBS) was added to each well. After 4 h of incubation
at 37 °C, 200 µL of the medium was transferred into a black-walled
96-well plate (Greiner Bio-one), and fluorescence was measured at
excitation and emission wavelengths of 530 and 590 nm, respectively.
(Spectra Max Gemini XS - molecular devices).
F-actin Fluorescence Labeling. After each incubation period, the
samples were rinsed with PBS and fixed with 4% (w/v) p-formaldehyde
in PBS for 10 min. After washing with PBS, cells were permeabilized
with 0.1% (v/v) Triton X-100 (Sigma) in PBS for 10 min and then
washed three times with PBS. We visualized cell cytoskeletal filamen-
tous actin (F-actin) by treating the cells with 5 U/mL Alexa Fluor 488
phalloidin (Molecular Probes) for 20 min in the dark. Cells were then
washed three times with PBS, and cell nuclei were counterstained with
4′,6-diamidino-2-phenylindole (DAPI) dye. Cells were examined using
an inverted fluorescence microscope (Axiovert 200M, Zeiss, Germany).
2.9. Mass Spectrometry. We performed mass spectrometry analysis
to determine the hydrolysis rate of the peptide by elastase. Mass spectra
were obtained using a LxQ MS detector, Thermo Electron Corporation.
Samples were dissolved in methanol and ionized by electrospray
ionization (ESI). The scan range was from m/z 100 to 2000 in positive-
ion mode.
2.10. In Vitro Release. The release of model compounds from SF/K
films was evaluated by the incorporation of FITC-BSA in the films.
FITC-BSA (2 mg/mL) was mixed with protein solutions before film
casting. The resulting films incorporating FITC-BSA were incubated
with 100 mM Tris-HCl buffer, pH 8.0, and 0.1 U/mL of PPE solution
at 37 °C. Solutions were changed every day. At determined time points,
aliquots were taken, and the FITC-BSA release was monitored by a
multiplate reader (Synergy HT W/TRF from BioTek) in the fluorescence
mode at emission wavelength of 490 nm. After each measurement, the
samples were added back to the medium to restore the equilibrium
weight loss (%) ) m0 - mf
m0
× 100 (1)
swelling ratio )
WS - Wd
Wd
(2)
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conditions. The quantification of the release was established by a
standard fluorescence curve. The release studies were performed in
triplicate and for a period of 7 days.
2.11. Release Kinetics. The release behavior of compounds from
polymeric systems can be determined by fitting the release data to the
empirical relationship given by the Ritger-Peppas equation.23
Where Mt is the amount of compound release at time t; M∞ is the amount
of compound at time approaching infinity; t is the release time; k is
the kinetic constant, and n is the diffusion exponent characteristic of
the release mechanism.
To determine n values for SF/K films, eq 3 is modified in eq 4, and
n is determined from the slope of the plot of log (% release) versus
log t.
2.12. Elastase Activity Determinations. The activity of PPE was
measured according to a method previously reported24 with some
modifications. In brief, 30 µL of enzyme was mixed with 900 µL of
reaction buffer 100 mM Tris-HCl, pH 8.0. The reaction was started by
the addition of 70 µL of 4.4 mM of Suc-Ala-Ala-Ala-p-nitroanilide, a
synthetic substrate for PPE. The reaction was carried out for 5 min at
37 °C, and the cleavage of the substrate was monitored spectrophoto-
metrically at 410 nm. One unit is defined as the amount of enzyme
that will hydrolyze 1.0 µmol of Suc-(Ala)3-pNA per minute at 25 °C,
pH 8.0.
To examine the inhibitory activity of 5(6)-carboxyfluorescein-
YCQPPWSATCF-OH, different peptide concentrations were added to
a fixed amount of PPE solution. The incubation was carried out a 37
°C, and at determined time points, aliquots were taken to monitor the
decrease in elastase activity determined as previously described.
To evaluate if the developed materials present inhibitory properties,
20 µM of peptide was mixed with the proteins solutions before film
casting. The films were incubated with PPE solution at 37 °C. In this
case, a fixed ratio of elastase solution per weight of film (0.2 mL/mg
film) was kept. The inhibitory activity was determined as described
above.
2.13. Statistical Analyses. Data are presented as average ( standard
deviation (SD). For multiple comparisons, homogeneity of variances
was assessed by Barlett’s test and after confirmation of the nonsig-
nificant difference of variances, one-way ANOVA, followed by post
hoc Bonferroni test. Differences were considered statistically significant
when p < 0.05. All calculations were performed using SPSS software
for Windows (version 16.0, SPSS).
3. Results and Discussion
In this work, films designed to be wound-dressing materials,
based on SF and keratin proteins with delivery properties, were
developed.
Our previous work22 indicated that SF and keratin are able
to establish intermolecular interactions like hydrogen bonding.
This fact was proven by the nonlinear trend of the different
parameters such as intensity ratio of amide II bands and enthalpy
variation (∆H) of the decomposition peak obtained, respectively,
from FTIR and DSC analysis. In addition, in the presence of
protease enzyme, the films underwent a slow biological
degradation, which is a function of the amount of keratin present
in the blend.
The combination of our results with the excellent biocom-
patibility both in vitro and in vivo,25,26 the promotion of cellular
adhesion and proliferation,27-29 and slow biodegradation already
demonstrated were the main factors to study the ability of SF/K
films to act as wound dressings.
3.1. Characterization of Protein Blend Films. Films were
prepared by casting the regenerated solutions of SF and keratin
on Petri dishes. After overnight solvent evaporation, uniform
and transparent films were obtained. Blend films with concen-
trations of: 100, 80, 60, 40, 20, and 0% of SF were prepared.
However, it was observed that with the increase in keratin in
the blend it was not possible to obtain a film with mechanical
integrity. Therefore, the maximum concentration of keratin that
can be used in the blend is 60%.
Degradability of a given material is a very important
parameter. It is directly linked to the drug release. The fast
polymer degradation is not desirable because a high drug
concentration will be released, which can be disadvantageous.
In vitro degradation of SF/K films was determined by
incubating protein films for several days in the presence of
elastase enzyme, which is one of the major components of the
chronic wounds exudate. PPE was used as a model.
It can be observed (Figure 1) that pure SF films present a
low degradation rate that remains constant over the time
exposure to elastase. This weight loss can be related with the
degradation of the small hydrolytically peptide sequences present
on the films even after crystallization.30
In the blends, it can be observed that the weight loss obtained
is a function of keratin content present in the film. At low keratin
amounts (20%), the degradation is relatively slower. At maxi-
mum keratin concentration (60%), the degradation took place
rapidly, and after 7 days, we obtained debris. Consequently,
the weight loss for this sample after 14 days of incubation was
not measured because of the high error associated with the
measurement.
It is important to notice that the weight loss obtained for the
blends is almost the same as the keratin content on the blend.
Therefore, the debris obtained for 40/60 SF/K film is probably
the fibroin that is not degraded but is not in sufficient amount
to maintain the mechanical structure of the film. From our
results, the maximum keratin amount that promotes a constant
degradation is 40%. The films kept in buffer solution showed
little or no degradation in 14 days.
On the wound dressing research, swelling is other important
parameter in materials characterization. If the material has the
ability to swell, then it will give moisture to the wound,
contributing to better healing.12 The swelling ratio was found
Mt
M
∞
) ktn (3)
log(% released) ) log(Mt/M∞) ) log k + n log t (4)
Figure 1. In vitro degradation of protein films incubated with 0.1 U/mL
of elastase solution at 37 °C for several days.
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to increase with the increase in keratin present in the blend
(Figure 2). Swelling results from diffusion and involves the
transport of ions or fluid into the biomaterial. The driving forces
of film formation by casting and solvent evaporation are
attributed to hydrophobic interactions and partial electrostatic
interactions.30 The increase in keratin amount decreases these
types of interactions because of the high content in polar residues
such as cysteine. This will promote a more open structure,
thereby increasing the film swelling.
SF/keratin films morphology was assessed by AFM. With
this analysis, we intend to determine the effect of surface
topography on the degradation as well on cell adhesion. In
Figure 3, the roughness height images are shown. The pure SF
film presented the higher roughness value, and its surface is
characterized by well-defined globular structures (Figure 3a),
as already observed by other authors.31 The formation of these
structures is a consequence of the methanol treatment.
In the blends, the addition of keratin enables the formation
of the globular structures, making the surface of the film
smoother. A decrease in the roughness value with the increase
in keratin in the blend can also be observed. (Data not shown.)
The addition of keratin alters the surface topography of the films,
and as a consequence, this might cause loss of film strength, as
already confirmed by in vitro degradation results.32
Biocompatibility is an essential parameter to be evaluated
for a biomaterial to be used in wound dressing. This was
assessed for our materials through the use of mouse embryonic
fibroblasts cultures. Two parameters were determined, cytotox-
icity and cell adhesion. The results of the indirect contact study
following fibroblast incubation with material extracts at different
dilutions showed no cytotoxicity effect of the protein film
extracts regardless of the extraction time. Figure 4 represents
the viability results for cells in contact with undiluted extract
(extraction time 72 h). In all cases, the metabolic activity of
cells in contact with the extracts was statistically equal or higher
than the one obtained with negative control (complete medium).
Direct contact study performed by seeding the cells on the
membranes showed a time-dependent increase in cell metabolic
Figure 3. AFM height images of pure and blend silk fibroin/keratin films. (a) 100 SF, (b) 80 SF, (c) 60 SF, (d) 40 SF, (e) 100 K. The area
measured was 10 × 10 µm.
Figure 2. Swelling ratio calculated after 24 h of incubation in 100
mM Tris-HCl buffer, pH 8.0 at 37 °C.
Figure 4. NIH 3T3 cell viability at 24 and 72 h of culture post contact
with extracts of the different materials tested (72 h extraction time).
The relative fluorescence units (RFUs) are presented for each material
and for each time point. The data represent a mean ( SD of six
independent measurements. The results obtained with the four
materials were compared among each other and with the controls: *
) significantly different from all of the other tested conditions; δ )
significantly different from 100 SF, 80/20 SF/K, and 60/40 SF/K.
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activity (Figure 5) that may suggest an increase in cell
proliferation. This was confirmed by cell microscopic observa-
tion where cell number increased as a function of time. However,
at the different time points studied, no significant differences
were observed among the materials and the control, suggesting
that the structures observed in AFM analysis on the film surface
did not affect cellular adhesion. Microscopic observations
showed similar cell number, distribution, and morphology on
all materials, regardless of the time of contact. At 48 h (Figure
6), cells exhibited an elongated morphology with fusiform
fibroblastic appearance already at confluence, as on the control
(TCPS). F-actin staining revealed a well-defined cytoskeleton
and numerous filopodia as well as cell-cell contacts. The same
result was observed by Shudong et al. using mouse fibroblast
cell lines.33 These results are in agreement with the literature,
indicating that the processing steps involving the use of solvent
systems will not cause detrimental effects on the resulting
material.34-37
Despite the fact that no cytotoxic effect was observed, it
should be considered for posterior work to test the materials
using cells from a human source and use them in vivo assays
conditions such as wound animal models. In this way, param-
eters like inflammatory reactions and wound closing and healing
will be determined.
3.2. In Vitro Release. The release profile of FITC-BSA from
SF/K films is presented in Figure 7. Considering that the loaded
amount as 100% and normalizing the amount of FITC-BSA
released in PPE solution, the profile is obtained. The release
can be divided into two phases: an initial burst phase in the
first 6 h and a continuous release over the remaining time.
The initial burst release might be related to the compound
molecules that are on the surface of the film. Nevertheless, for
pure SF film, the release is controlled and slow. In the blends,
the release is fast and is dependent on the keratin amount.
Methanol treatment leads to higher crystallinity, making the film
Figure 6. Fluorescent labeling of F-actin (green) and DNA (blue) of NIH 3T3 cells cultured for 48 h on TCPS (A and B) and discs prepared from
80/20 SF/K film (C and D).
Figure 5. NIH 3T3 cell proliferation on discs of 100 SF, 80/20 SF/K,
and 60/40 SF/K. The relative fluorescence units (RFUs) are presented
for each material and for each time point. The data represent a mean
( SD of three independent measurements.
Figure 7. In vitro release profile of the peptide from SF/K films
incubated with 0.1 U/mL of PPE (bold lines) and 100 mM Tris-HCL
buffer solution (dashed lines).
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rigid and compact. Although this treatment leads to physical
cross-linking of the films, incorporation of keratin, of hydrolytic
nature, had a pronounced effect on the FITC-BSA release. This
may be due to keratin dissolution causing more void volume
for the release of the compound. The methanol treatment does
not provide adequate stability for sustained release over days
for films with high keratin content.
The previous results obtained from mechanical tests22 indicate
that increase in keratin content leads to the decrease in the
mechanical strength of the films. This will allow the formation
of cracks in the film from where the compound can rapidly
diffuse out.
To evaluate if the release from SF/K films is controlled by
diffusion or dominated by film degradation, we fit experimental
data into the Ritger-Peppas equation, as described in Section
2.11.
For a thin film, a Fickian diffusion of first-order is observed
when n has the limiting value of 0.5; when n ) 1, case II
transport (polymer relaxation/degradation) occurs, leading to
zero-order release. When n lies between 0.5 and 1, anomalous
transport is observed, coupling Fickian diffusion and polymer
degradation.38
It can be concluded from the data obtained in Table 1 that
samples 100 SF and 80/20 SF/K indicate that the release is
dominated by Fickian diffusion of first-order. The n value
obtained for the blend 80/20 SF/K is closer to 0.5, indicating
that the addition of 20% of keratin decreases the rigidity of the
compact structure of pure SF film, improving the release
properties. There is an increase in film swelling and conse-
quently the diffusion of FITC-BSA.
For the blend 60/40 SF/K, the release is non-Fickian nature.
“n” lies between 0.5 and 1, indicating that the release is due to
the combination of diffusion and film degradation.
The sample 40/60 SF/K shows the highest “n” value (n > 1),
indicating that for this sample the release is totally dominated
by film degradation. The sample 40/60 SF/K presents higher
swelling ratio and degradation rate and, as a consequence, higher
release rate. Furthermore, correlation coefficient “R2” is above
the permissible range, that is, R2 ) 0.95, indicating the validity
of the results.
3.2. Inhibitory Activity. The major goal of this work is the
development of wound dressings with specific biological
functionality: the inhibition of high levels of elastase. For this
purpose, it was important to determine the inhibitory activity
of the synthetic peptide selected.
Several studies have been made to control elastase activity
and promote chronic wound healing. A cotton-bound serine
protease inhibitor has shown to decrease elastase activity on a
chronic wound fluid.39 The release of epidermal growth factor
(EGF) from electrospun silk mats had also shown the promotion
of wound healing.40 Even so, there are few or no studies on the
release of synthetic peptides from protein films to promote the
inhibition of high levels of elastase found on chronic wounds
exudate. Therefore, this work presents an original system to
control high levels of elastase found on chronic wounds.
To determine the inhibitory activity of the peptide, increasing
peptide amounts were incubated with elastase solution at 37
°C. At determined time points, aliquots were taken to determine
the residual activity. From the results obtained on Table 2, it
can be seen that for high peptide concentrations PPE activity
rapidly decreases, suggesting its ability to act as an elastase
inhibitor. For lower peptide concentrations, the decrease in half-
life time of PPE is not so pronounced. It can be concluded that
the decrease in PPE activity is dependent on peptide concentration.
To understand the inhibition mechanism of this peptide,
assays were performed to determine the inhibition constant.
When the residual activity was plotted against substrate
concentration, it was observed that the elastase activity curve
in the presence of peptide inhibitor converge, over the time, to
the curve of elastase activity without peptide. This result might
indicate that the peptide is being hydrolyzed by elastase, which
was confirmed by mass spectrometry analysis. (Data not shown.)
Hydrolytic stability of BBI peptides as the one selected for
this study is very important. In general, hydrolysis rates are low
and are affected by the peptide sequence.21,41,42 The hydrolysis
of our peptide occurred after 6 h of incubation with PPE.
Nevertheless, a high decrease in elastase activity was observed
in the presence of peptide (Table 2), suggesting that its function
was not affected by hydrolysis. Simulations performed based
on the decrease in the mass value (from m/z ) 1659.83 to m/z
) 1512.75) indicated that hydrolysis might occur in one amino
acid residue of the C-terminal. This probably will not change
the conformational structure of the peptide, which allows it to
retain the inhibitory activity. However, this fact has to be further
investigated by other techniques such as NMR analysis.
To determine if the peptide retains its inhibitory activity after
incorporation onto SF/K films, films with 20 µM of peptide
were incubated with PPE solution for 24 h. At determined time
points, the PPE activity was measured, and the results are
presented in Table 3 as half-life time of PPE. It can be seen
that for 100 SF and 80/20 SF/K films, incorporation of the
peptide increases the half-life time of PPE (22.7 ( 4.2 and 17.5
( 3.3 h, respectively) when compared with the peptide alone
(15.3 ( 2.1 h).
This result indicates the ability of the SF/K films to act as
elastase inhibitors wound dressings. For the blends 60/40 and
40/60 SF/K, the half-life time of PPE decreases in comparison
with the peptide in solution (Table 3). The release of the peptide
Table 1. Model Compound Release Kinetic Data Obtained from
Fitting Experimental Release Data to Ritger-Peppas Equation
where “n” Is the Diffusion Exponent and R2 Is the Correlation
Coefficient
sample n R2
100 SF 0.411 0.996
80/20 SF/K 0.507 0.997
60/40 SF/K 0.551 0.997
40/60 SF/K 1.03 0.993
Table 2. Half-Life Time of PPE Activity after 24 h of Incubation
with Different Peptide (5(6)-Carboxyfluorescein-YCQPPWSATCF-
OH) Concentrations at Room Temperature
sample t1/2 (h)
PPE 28.3 ( 3.7
PPE + 20 µM 15.3 ( 2.1
PPE + 40 µM 11.6 ( 2.3
PPE + 60 µM 5.3 ( 1.2
PPE + 80 µM 3.8 ( 1.1
Table 3. Half-Life Time of PPE after 24 h of Incubation with SF/K
Films with 20 µM of Peptide Incorporated
sample activity loss (%)
PPE 28.3 ( 3.7
PPE + 20 µM 15.3 ( 2.1
100 SF 22.7 ( 4.2
80/20 SF/K 17.5 ( 3.3
60/40 SF/K 14.1 ( 2.1
40/60 SF/K 8.1 ( 1.1
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from SF/K films was also monitored for 24 h by fluorescence
measurements. (Data not shown.) With the data obtained, it was
not possible to determine the release mechanism. Nevertheless,
the release kinetics obtained with FITC-BSA allow us to
conclude that in the first 24 h the decrease in PPE activity is
mainly due to the swelling ratio.
The high swelling ratio obtained for 60/40 and 40/60 SF/K
blends means that PPE solution is rapidly in contact with
inhibitor peptide into the film, causing the fast decrease in PPE
activity. If the measurements were prolonged for more time,
then the release of peptide and consequently the decrease in
PPE activity will be more influenced by degradation rate.
In a heterogeneous system like this, it is important to
determine the protein, PPE, adsorption to the SF/K films. In
particular, it is important to distinguish the decrease in PPE
activity due to the peptide action from the decrease in activity
due to adsorption to the films.
To evaluate this difference, films with and without peptide
were incubated with PPE solution, and the decrease in PPE
activity was monitored. It can be seen from Figure 8 that when
PPE was incubated with SF/K films without peptide, the
decrease in activity is much lower in comparison with films
with peptide. This result validates the action of the peptide when
it is incorporated into the SF/K films. Furthermore, it can be
seen that protein (PPE) adsorption is also a function of the
keratin amount.
4. Conclusions
This study evidenced that blending SF and wool keratin
results in a protein matrix suitable for sustained delivery of
elastase inhibiting agents. The release pattern is affected by the
degradation rate of the films, and the knowledge of this allows
the design of matrices with controlled release ability.
In vitro degradation was evaluated under PPE solution, and
it was found that biological degradation is a function of keratin
amount present in the film. The SF/K films were also tested for
in vitro release using PPE solution as release medium. The
results presented indicated that the release mechanism of
molecules from the films is dominated by film degradation and
diffusion. In this work, the dehydrating step of methanol
treatment was used to control the structure and stability of the
self-assembly SF/K films. Pure fibroin films (100 SF) present a
rigid and compact structure; the addition of keratin leads to a
decrease in -sheet content, causing a more open structure that
will affect swelling, degradation, and release rates. Furthermore,
our study indicated that the protein films developed are not
cytotoxic and are able to support the adhesion of fibroblasts
cells, making them suitable for biomedical applications such
as wound dressings.
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